Stay updated with breaking news from Kronos Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kronos Bio, Inc. (NASDAQ:KRON – Get Free Report) insider Christopher Dinsmore sold 10,032 shares of Kronos Bio stock in a transaction on Tuesday, December 12th. The stock was sold at an average price of $1.30, for a total transaction of $13,041.60. Following the completion of the transaction, the insider now owns 268,335 shares in the […]
SAN MATEO, Calif. and CAMBRIDGE, Mass., Dec. 04, 2023 -- Kronos Bio, Inc. , a company dedicated to transforming the lives of those affected by cancer, today announced that Jorge DiMartino M.D.,...
SAN MATEO, Calif. and CAMBRIDGE, Mass., Nov. 27, 2023 -- Kronos Bio, Inc. , a company dedicated to transforming the lives of those affected by cancer, today announced that Norbert Bischofberger,...
/PRNewswire/ -- The "Cyclin-Dependent Kinase Inhibitor - Pipeline Insight, 2023" drug pipelines has been added to ResearchAndMarkets.com's offering....
